AstraZeneca and NASSCOM – CoE IOT strengthen their collaboration to foster digital solutions for addressing Non-Communicable Diseases (NCDs) in India

NASSCOM enters strategic collaboration with China’s I·Campus to accelerate healthcare innovation and cooperation in life sciences & healthcare sector
 

Bangalore, Sep 19, 2019: A day-long flagship health-tech event of NASSCOM, LHIF “Re-defining the Healthcare Landscape - The Digital Shift”, was inaugurated by some of the leading names in the industry.  LHIF (Lifesciences & Healthcare Innovation Forum) is a platform created by NASSCOM to drive digital transformation in the Lifesciences and Healthcare Industry. This Forum is one of the largest neutral eco-systems comprising stakeholders from Pharmaceutical Industry, Med-Tech Companies, Health Insurance organizations, Hospitals, Radiology and Imaging companies, Technology Companies, Industry Associations, Startups, Academia and government bodies.

Nearly 300+ participants from across the life sciences & healthcare supply chain attended from all over India.

Keynotes were given by Dr. Devi Shetty, Chairman & Executive Director, Narayana Health, Mr. Nalinikanth Gollagunta, Managing Director, Wipro GE Healthcare, Mr. Niclas Jacobson, Deputy Director - Ministry of Health and Social Affairs, Govt. of Sweden and Mr. Gagan Singh, Managing Director, AstraZeneca Pharma India Ltd.

The event discussed a wide range of topics in healthcare such as Med-Tech Innovation in Healthcare, The Digital Doctor Of The Future, Societal Impact Through Health-Tech, Cloud Computing In Healthcare & Lifesciences, Building a Unified Digital Health Platform and Current Trends in Healthcare today.  Sankara Nethralaya Medical Research Foundation presented a collection of industry success stories in digital adoption.

In addition, the #LHIF Startup Awards were presented to SIX high-impact and tech-driven healthcare startups breaking new ground in innovation & healthcare.

Speaking on the occasion, Ms. Debjani Ghosh, President, NASSCOM states, “Advanced technology adoption in Indian healthcare sector is poised for substantial growth as it continues to emerge as a game-changer in the delivery of quality healthcare services. Technological innovations and interventions are crucial to convert today’s expensive medical discoveries into affordable solutions. The NASSCOM LHIF is an important step in developing a closer partnership between health-tech companies, global healthcare organisations, academia and the government to work collaboratively in deploying proven innovation to solve critical healthcare challenges present today and at pace to enable the local population to get the best and most efficient healthcare services possible. NASSCOM’s collaboration with AstraZeneca is one such effort in this area to further promote digitally-enabled technologies, across regions, so that evidence can be generated, and tech adoption is scaled at speed, both domestically and internationally.”

Delivering the opening Keynote address at the forum, Gagan Singh, Managing Director, AstraZeneca Pharma India Limited shared that both NASSCOM and AstraZeneca are committed to strengthening their collaboration towards driving the digital healthcare agenda. This partnership would focus on healthcare delivery interventions via digital technologies and collaboration towards Healthcare Innovation Centers showcasing the impact of such solutions across the patient journey, from early diagnosis, to treatment and wellness. NASSCOM & AstraZeneca’s have an existing partnership under the iDREAM programme – a health tech start-up accelerator programme and incubation centre in Bengaluru that supports start-ups in bringing innovative and frugal solutions that can help in the management of NCDs in India and beyond.  

AstraZeneca’s iDREAM platform is a global initiative that seeks to create innovative solutions for improving patient’s lives through partnerships with start-ups, companies and academia to develop patient-centric solutions.

Earlier this month on 7th September’19, AstraZeneca having had the experience in establishing similar centers in other part of the world, led a delegation of senior leaders from AstraZeneca and NASSCOM to Wuxi City in Jiangsu province, China, to study the set up and governance of the Healthcare IOT Innovation Centre there.

During this visit, NASSCOM also entered a strategic partnership with the Wuxi International Life Science Innovation Campus (I·Campus), an innovation incubation platform offering services in R&D, commercialization and professional services in the life sciences industry, co-built by the Wuxi Municipal Government, the Wuxi National High-tech District and AstraZeneca. The collaboration will support healthcare tech start-ups accelerate healthcare innovation and promote international cooperation and development of the lifesciences and healthcare industry across the borders. The key highlights of the MOU include;

1.     Both parties will strengthen academic exchanges, establish the mechanism of mutual visits and personnel exchanges, and share development and management experience to promote common objectives.

2.     NASSCOM will encourage and facilitate member companies to develop in I·Campus, and I·Campus will also recommend on-campus companies to seek for cooperation opportunities with NASSCOM, provide policy support and advisory services, and promote the marketing of their products.

3.     Both parties will invite the management group of the counterpart party and their companies to participate in their annual major events and activities to promote in-depth exchanges and cooperation. Both parties will promote each other in their own countries for upgrading the popularity and reputation of each other.

4.     The I·Campus will invite the CEO of Centre of Excellence, NASSCOM to act as a member of the I·Campus Advisory Committee to attend the annual meeting of the Advisory Committee, provide suggestions and recommendations on the management and development of the I·Campus, and provide consultancy and guidance for the on-campus companies.

5.     The I·Campus will provide office and activity space for the NASSCOM and its identified members companies.

About AstraZeneca Pharma India Limited

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism and Respiratory. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

AstraZeneca Pharma India Limited (AZPIL) was established in 1979 and is marking its 40th year of long-standing commitment to patients in India. It is headquartered at Bengaluru, Karnataka. AstraZeneca India has a workforce of over 1400 employees across the country committed to deliver great medicines to patients through innovative science and global excellence in development and commercialization. For more information, please visit: www.astrazeneca.com/india

About iDREAM

iDREAM platform seeks to identify and attract local scientific excellence in order to boost drug research and development. It reinforces our commitment to expand the frontiers of science and create innovative solutions to improve patients’ lives and positively impact wider society. Under the iDREAM platform umbrella, we partner with start-ups, companies, academia and venture capitalists to identify and develop products, patient-centric solutions and Life Cycle Management (LCM) opportunities. We also partner with leading universities to deliver best-in-class educational initiatives. These partnerships are centered in our iDREAM biomedical hubs, which form part of AstraZeneca’s Global Health Innovation Hub network, the first of which opened in Russia in July 2018, and subsequently in Brazil, Taiwan, China, Argentina and India.

Find out more about iDREAM and our Hubs here.

About the Wuxi International Life Science Innovation Campus (I·Campus)

I·Campus is a collaboration between the Wuxi National High-tech District government, Wuxi Municipal government, Jiangsu Provincial government, and AstraZeneca - a global, science-led biopharmaceutical company.  Located in the Wuxi National High-tech District with a 300,000m2 core R&D area, I·Campus aims to create an innovation incubation platform that integrates R&D, commercialization and professional services, helping to accelerate healthcare innovation and life sciences in China by attracting and leveraging domestic and overseas talent and resources in cutting-edge healthcare technology.

About NASSCOM – CoE IOT

The NASSCOM Center of Excellence is the largest collaborative innovation platform in the emerging technologies of IoT, Analytics, AI/ML, AR/VR and Robotics for Digital Transformation. It is part of the Digital India Initiative to jump start and drive the emerging technologies ecosystem in India taking advantage of India's IT strengths and help country attain a leadership role in the convergent area of hardware and software.

The main objective of the CoE is to help the Indian Deep-Tech Startups leverage cutting edge technologies to build market ready products. Through the Startups Program, we aim to build industry capable talent in an entrepreneurial ecosystem by facilitating Incubation, Funding, Acceleration, Industry Connect and Mentoring.

NASSCOM CoE was setup in July 2016 as part of the Digital India initiative of MeitY, with the objective of aiding innovative start-ups in the emerging technologies. NASSCOM CoE-IoT has center in Bangalore and Gurgaon. New Centers are being established at Gandhinagar and Visakhapatnam. NASSCOM has also set up a new CoE for Data Sciences and Artificial Intelligence in Bangalore and a new Center is being established shortly at Hyderabad.

About NASSCOM

The National Association of Software and Services Companies (NASSCOM®) is the premier trade body and chamber of commerce of the Tech industry in India and comprises over 2800-member companies including both Indian and multinational organisations that have a presence in India. Our membership spans across the entire spectrum of the industry from start-ups to multinationals and from products to services, Global Service Centers to Engineering firms. Guided by India’s vision to become a leading digital economy globally, NASSCOM focuses on accelerating the pace of transformation of the industry to emerge as the preferred enablers for global digital transformation.  Our strategic imperatives are to reskill and upskill India’s IT workforce to ensure that talent is future-ready in terms of new-age skills, strengthen the innovation quotient across industry verticals, create new market opportunities - both international and domestic, drive policy advocacy to advance innovation and ease of doing business, and build the Industry narrative with focus on Talent, Trust and Innovation. And, in everything we do, we will continue to champion the need for diversity and equal opportunity.

NASSCOM has played a key role in not just the growth of the Industry to become a $180+Billion industry today, but we have helped establish the Tech industry in India as one of the most trusted partners, globally. NASSCOM continues to make significant efforts in contributing towards India’s GDP, exports, employment, infrastructure development and global visibility. Our membership base constitutes over 95% of the industry revenues in India and employs over 4 million professionals, and as technology blends into every aspect of the economy, we expect the industry to become key driver of growth, development and inclusion for the country. Our mission is to make India a global hub for Innovation and Talent so when the world thinks Digital, the world will think India

 

Media Contact:

Varsha Das     | Mobile: 9008777884 | Email: varsha.das1@astrazeneca.com

Kavita Doshi    | Landline: +91 120 4990200| Email: kavita@nasscom.in

Satyaki Maitra   | Mobile: +91 9958041503 | Email: satyaki.maitra@genesis-bcw.com

Kritarth Srivastava | Mobile: +91 7289870408 | kritarth.srivastava@genesis-bcw.com